EdenTree Asset Management’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.3M Buy
102,568
+15,428
+18% +$2.02M 3.69% 5
2025
Q4
$11.9M Sell
87,140
-39,850
-31% -$5.73M 3.63% 5
2025
Q3
$18.7M Buy
126,990
+16,000
+14% +$2.22M 4.51% 4
2025
Q2
$14.4M Buy
110,990
+28,141
+34% +$3.41M 3.98% 4
2025
Q1
$9.9M Sell
82,849
-100
-0.1% -$12.4K 3.32% 5
2024
Q4
$9.63M Buy
82,949
+12,000
+17% +$1.52M 2.79% 8
2024
Q3
$9.57M Sell
70,949
-100
-0.1% -$13.4K 2.77% 11
2024
Q2
$9.63M Buy
71,049
+1,850
+3% +$252K 3.05% 8
2024
Q1
$8.94M Sell
69,199
-9,662
-12% -$1.17M 2.84% 12
2023
Q4
$9.02M Buy
78,861
+58,026
+279% +$5.79M 2.79% 12
2023
Q3
$1.9M Buy
20,835
+14,035
+206% +$1.45M 0.74% 32
2023
Q2
$766K Buy
+6,800
New +$719K 0.26% 54

Other funds holding XYL

EdenTree Asset Management's XYL Position: Q1 2026 in Review

EdenTree Asset Management increased its Xylem (XYL) stake by 18% in Q1 2026, buying an estimated $2.02M and bringing the position to 102,568 shares worth $12.3M. The position accounts for 3.69% of the portfolio, ranked #5.

EdenTree Asset Management first reported a position in XYL in Q2 2023 and has held it in 12 quarters since. The position peaked at $18.7M in Q3 2025. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • EdenTree Asset Management held 102,568 shares of Xylem worth $12.3M as of Q1 2026.
  • EdenTree Asset Management bought 15,428 Xylem shares in Q1 2026, an estimated $2.02M.
  • Xylem made up 3.69% of EdenTree Asset Management's portfolio in Q1 2026, its #5 holding.
  • EdenTree Asset Management first reported a position in Xylem in Q2 2023 and has held it in 12 quarters since.
  • EdenTree Asset Management's Xylem position peaked at $18.7M in Q3 2025.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on EdenTree Asset Management's 13F filing for Q1 2026, filed 14 May 2026.